









Markets
/
Stocks
/
nasdaq-mlab
/

Mesa Laboratories Inc

MLAB

93.270USD

+2.070+2.27%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

515.30MMarket Cap

141.92P/E TTM



Mesa Laboratories Inc

93.270

+2.070+2.27%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Mesa Laboratories Inc

Currency: USD Updated: 2026-02-06

Key Insights

Mesa Laboratories Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 45 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 99.00.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Mesa Laboratories Inc's Score

Industry at a Glance

Industry Ranking

45 / 205

Overall Ranking

135 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

Mesa Laboratories Inc Highlights

StrengthsRisks

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.

Overvalued

The company’s latest PE is 141.92, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 4.70M shares, decreasing 16.51% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 321.90K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of 1.06.

Analyst Rating

Based on 3 analysts

Buy

Current Rating

99.000

Target Price

+8.55%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Mesa Laboratories Inc is 8.34, ranking 48 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 65.13M, representing a year-over-year increase of 3.64%, while its net profit experienced a year-over-year increase of 316.59%.

Score

Industry at a Glance

Previous score

8.34

Change



Financials

6.39

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

9.84

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.79

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.47

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.19

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Mesa Laboratories Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Mesa Laboratories Inc is 6.21, ranking 168 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 141.92, which is 643.23% below the recent high of 1054.75 and 718.76% above the recent low of -878.12.

Score

Industry at a Glance

Previous score

6.21

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 45/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Mesa Laboratories Inc is 7.33, ranking 134 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 95.00, with a high of 115.00 and a low of 75.00.

Score

Industry at a Glance

Previous score

7.33

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts

Buy

Current Rating

99.000

Target Price

+8.55%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

Mesa Laboratories Inc

MLAB

Stryker Corp

SYK

Medtronic PLC

MDT

Dexcom Inc

DXCM

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Mesa Laboratories Inc is 8.94, ranking 21 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 101.78 and the support level at 81.12, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.78

Change

0.16

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(1)

Buy(4)

Indicators

Value

Direction

MACD(12,26,9)

1.900

Buy

RSI(14)

67.345

Neutral

STOCH(KDJ)(9,3,3)

69.439

Buy

ATR(14)

4.410

Low Volatility

CCI(14)

134.774

Buy

Williams %R

23.554

Buy

TRIX(12,20)

0.149

Sell

StochRSI(14)

100.000

Overbought

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

88.806

Buy

MA10

84.371

Buy

MA20

84.748

Buy

MA50

81.980

Buy

MA100

77.321

Buy

MA200

83.568

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Mesa Laboratories Inc is 7.00, ranking 80 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 85.13%, representing a quarter-over-quarter decrease of 8.22%. The largest institutional shareholder is The Vanguard, holding a total of 321.90K shares, representing 5.83% of shares outstanding, with 17.07% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

327.65K

-53.77%

The Vanguard Group, Inc.

Star Investors

321.72K

-17.10%

Ranger Investment Management, L.P.

209.70K

-2.14%

Geneva Capital Management LLC

191.39K

-3.87%

Simcoe Capital Management, LLC

190.93K

Royce Investment Partners

Star Investors

148.56K

-40.00%

Owens (Gary M)

148.26K

+8.45%

Janus Henderson Investors

145.65K

+28.57%

Diamond Hill Capital Management Inc.

Star Investors

123.38K

+218.00%

Atlanta Capital Management Company, L.L.C.

139.90K

-4.14%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Mesa Laboratories Inc is 5.99, ranking 68 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.86. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Mesa Laboratories Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.